Physician profile
Michael L Smith
NPI 1013993955
$9,515.29
in general payments reported to CMS, 2019-2025
15 companies · $5,599 in 2025
The $5,599 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $168 · 2021: $1,234 · 2022: $217 · 2023: $1,836 · 2024: $160 · 2025: $5,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,378 · Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,378.33 |
| Food and Beverage | $1,217.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $3,738.12 | 2021-2025 | |
| Alphatec Spine, INC | $3,238.09 | 2024-2025 | Other - Miscellaneous, Safeop |
| Curonix LLC | $744.92 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $673.47 | 2025 | Mako, N/A |
| Medtronic USA, INC. | $301.61 | 2019 | |
| Depuy Synthes Sales INC. | $177.96 | 2020-2023 | Actis |
| Globus Medical, INC. | $135.92 | 2022-2024 | Excelsius Deformity |
| Titan Surgical Group, LLC | $125.72 | 2021 | |
| Nevro Corp. | $125.28 | 2021-2022 | |
| Cerapedics INC. | $115.25 | 2021-2024 | I-Factor Peptide Enhanced Bone Graft |
| Anika Therapeutics, INC. | $40.56 | 2021 | |
| Carlsmed, INC. | $37.23 | 2025 | Aprevo |
| Nuvasive, INC. | $35.52 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.89 | 2020 | |
| Zimmer Biomet Holdings, INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.